Surgical resection of HCC previously reported rates of 5-year survival rate of 45% to 50% from 65% to 70% for transplantation.64 However, a direct comparison of resection on survival to transplant data outside OUTSIDE a study difficult to . do The favorable results for transplantation probably reflects a more stringent selection of the patients.73, 74 first results of liver transplantation purchaseABT-888 for HCC allstage with a high recurrence and early lower survival rate after 5 years compared with Affiliated Other indications for OLT.75 Asa result of this discouraging experiences in the 1990s as a counter-indication for transplantation HCCwas in many centers BTA.
Subsequently End was observed, Random in the investigation of liver explants Lligen small HCC not pr Operative Thomas et al 3996 © recognized order YN968D1 in 2010 by the American Society of Clinical Oncology Journal of Clinical Oncology imaging had no impact negative impact on earnings after transplantation. The HCC patients meet these criteria had to survive the same post-transplant compared to patients without HCC, with four years and the actuarial survival rates of recurrence of 75% and 83% free, respectively.76, 77 These results were from multiple centers best CONFIRMS and led to the acceptance of patients with cirrhosis of the liver transplant forHCCin that meet these criteria.HCCpatients undergoing OLT in the United Network for Organ Sharing criteria are the median of 5-year survival rates of 65% to 80%. While there is interest in expanding the criteria for liver transplantation for patients with HCC for patients with tumors gr He and numerous, 78 81 These criteria have not been accepted or approved.
Selected COOLED patients with HCC Descr Nkt on the liver, the disease does not train Lokoregion accessible resection or transplantation Re to be considered. To z Select percutaneous ethanol injection, cryotherapy, radiofrequency ablation or microwave, stereotactic radiotherapy, radioactive Mikrosph Ren, trans-arterial embolization and transarterial chemoembolization. W lokoregion During nonresectional Re treatments are not curative, these Ans tze Not produce destruction Tion of the tumor with preservation of nontumorous liver parenchyma and can serve as a bridge to more definitive therapy, such as liver transplantation or as salvage therapy for a recurrence after resection are 0.
82 86 using radio waves through an electrode inserted directly into a tumor sent in order to create a zone of thermal necrosis to destroy the tumor ren. RFA can be performed percutaneously, laparoscopically or through an open section and is cmin in tumors with a diameter of 3. Bug’s tumors require multiple overlapping ablations in the control or the use of multiple probes tables. Traditionally, GFR has been through the Unf Ability, pr Precise in Table 1 beautiful COLUMNS Descr Nkt. Staging and prognostic systems in HCC Author / Reference Staging Staging System Name System Acronym system features result / EDGE et al, 36 Vauthey et al, 37 Gunderson et al.38 AJCC / UICC TNM 6th Edition American Joint Committee on Cancer / International Union Against Cancer tumor metastases I, II, III, IV, tumor size E and number, Gef Invasion, extrahepatic disease, fibrosis. Llovet and Barcelona Clinic Liver Cancer BCLC AL39 A, B, C, D size E of the tumor, the patient’s clinical condition, C